R&D strategy – Talk Bio

Actionable Insights Powered by AI

GSK’s Strategic Approach to Deal-Making and Expansion Beyond Obesity with GLP-1s

GSK, GLP-1s, Obesity, Deal-making, Strategic expansion, Pharmaceutical innovation, R&D strategy